COVID Vaccines Getting Parallel Review: ACIP To Begin Process Before FDA Decisions

With goal of distributing vaccines within 24 hours of emergency use authorization, HHS is hoping to convene CDC's ACIP concurrent with the FDA review, Alex Azar says.

scenic road
US FDA and ACIP will move in parallel to review the COVID vaccines. • Source: Shutterstock

More from Vaccines

More from Pink Sheet